Burden of aspergillosis-related hospitalizations in the United States.
In the United States in 1996, there were an estimated 10,190 aspergillosis-related hospitalizations (95% confidence interval [CI], 9000-11,380); these resulted in 1970 deaths (95% CI, 1659-2280), 176,272 hospital days (95% CI, 147,163-206,275), and $633.1 million in costs (95% CI, $492.0-$780.2 million). The average hospitalization lasted 17.3 days (95% CI, 16.1-18.6) and cost $62,426 (95% CI, $52,670-$72,181). Although aspergillosis-related hospitalizations account for a small percentage of hospitalizations in the United States, patients hospitalized with the condition have lengthy hospital stays and high mortality rates.
Dasbach
E J
EJ
Merck Research Laboratories, Blue Bell, PA 19422, USA. erikdasbach@merck.com
Davies
G M
GM
Teutsch
S M
SM
D000293:Adolescent; D000328:Adult; D000368:Aged; D001228:Aspergillosis / Q000175:diagnosis / Q000401:mortality / Q000628:therapy; D005260:Female; D006760:Hospitalization / Q000191:economics / Q000706:statistics & numerical data; D006764:Hospitals, Community; D006801:Humans; D007902:Length of Stay / Q000191:economics / Q000706:statistics & numerical data; D008297:Male; D008875:Middle Aged; D010351:Patient Discharge / Q000706:statistics & numerical data; D014481:United States / Q000453:epidemiology